The Earlier the Better: Probing Malignancies in Newborns

(L-R) Prof.Wolfgang Holzgreve, Prof. Marek Glazerman, Prof. Israel Meisner

Building on their established international partnership, GE Healthcare and Rabin Medical Center are developing innovative products and working on creative medical solutions to facilitate the early diagnosis of medical problems in pregnant women and their fetuses. An international data registry on fetal tumors is already in progress, which will assist in treating malignant conditions in both fetuses and newborns. Prof. Israel Meisner, head of RMC's Obstetric Ultrasound Unit, said tumors such as Neuroblastoma can be fully cured if discovered early in a fetus, and he believes this registry is important.

The data registry project was inaugurated during a conference at Rabin Medical Center on Women's Healthcare organized by GE Healthcare Israel, headed by Tony Bachar, and by the Rabin Medical Center's Women's Hospital, headed by Prof. Marek Glazerman. Among the honored guests present was Prof. Wolfgang Holzgreve, head of obstetrics and gynecology at the renowned University of Basel in Switzerland.

Related Articles

Late Pregnancy Research and Consequences

Today more and more woman are giving birth at a later age, yet according to a recent study done by Prof. Yariv Yogev, there are many risks involved.

read more »

Rabin Medical Center Saves Breast Cancer Patients with New Mammography Techniques

A researcher at Zebra Medical Vision has created a new mammography algorithm that uses machine and deep learning to diagnose breast cancer (BC), with results that the company claims are superior to those achieved using current methods.

read more »

Israeli Researchers Identify Protein that Protects Brain Cells from Parkinson's

The protein, called NID-13, has proven effective in lab mice; researchers have registered a patent.

read more »